Advertisement

Topics

"Pfizer Drug Could Spell Long Term Trouble Sarepta" Drugs and Medication Database

17:13 EST 20th January 2019 | BioPortfolio

Here are the most relevant "Pfizer Drug Could Spell Long Term Trouble Sarepta" Drugs and Medications that we have found in our database.

More Information about "Pfizer Drug Could Spell Long Term Trouble Sarepta" on BioPortfolio

We have published hundreds of Pfizer Drug Could Spell Long Term Trouble Sarepta news stories on BioPortfolio along with dozens of Pfizer Drug Could Spell Long Term Trouble Sarepta Clinical Trials and PubMed Articles about Pfizer Drug Could Spell Long Term Trouble Sarepta for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pfizer Drug Could Spell Long Term Trouble Sarepta Companies in our database. You can also find out about relevant Pfizer Drug Could Spell Long Term Trouble Sarepta Drugs and Medications on this site too.

Showing "Pfizer Drug Could Spell Long Term Trouble Sarepta" Drugs and Medications 1–25 of 34

Probably Relevant

Vyndaqel [Pfizer Labs Division of Pfizer Inc.]

Vyndaqel

Sutent [Pfizer Laboratories Div Pfizer Inc]

These highlights do not include all the information needed to use SUTENT safely and effectively. See full prescribing information for SUTENT. SUTENT (sunitinib malate) capsules, for oral useInitial U.S. Approval: 2006

Atorvastatin calcium [Northwind Pharmaceuticals]

NA

Eucrisa [Pfizer Laboratories Div Pfizer Inc]

These highlights do not include all the information needed to use EUCRISA safely and effectively. See full prescribing information for EUCRISA. EUCRISA™ (crisaborole) ointment, 2%, for topical useInitial U.S. Approval: 2016

Possibly Relevant

Viagra [Pfizer Laboratories Div Pfizer Inc]

These highlights do not include all the information needed to use VIAGRA safely and effectively. See full prescribing information for VIAGRA. VIAGRA® (sildenafil citrate) tablets, for oral useInitial U.S. Approval: 1998

Inlyta [Pfizer Laboratories Div Pfizer Inc]

These highlights do not include all the information needed to use INLYTA safely and effectively. See full prescribing information for INLYTA. INLYTA (axitinib) tablets for oral administration Initial U.S. Approval: 2012

Ibrance [Pfizer Laboratories Div Pfizer Inc]

These highlights do not include all the information needed to use IBRANCE safely and effectively. See full prescribing information for IBRANCE. IBRANCE (palbociclib) capsules, for oral use Initial U.S. Approval: 2015

Inlyta [U.S. Pharmaceuticals]

These highlights do not include all the information needed to use INLYTA safely and effectively. See full prescribing information for INLYTA. INLYTA (axitinib) tablets for oral administration Initial U.S. Approval: 2012

Tessalon [Pfizer Laboratories Div Pfizer Inc]

TESSALON 100 mg Perles (benzonatate, USP)

Fragmin [Pfizer Laboratories Div Pfizer Inc]

These highlights do not include all the information needed to use FRAGMIN safely and effectively. See full prescribing information for FRAGMIN. FRAGMIN (dalteparin sodium) injection, for subcutaneous useInitial U.S. Approval: 1994

Bacitracin [Pharmacia and Upjohn Company LLC]

Bacitracin for Injection, USP

Cortisporin [Pfizer Laboratories Div Pfizer Inc]

CORTISPORIN Cream(neomycin and polymyxin B sulfates and hydrocortisone acetate cream, USP)

Silvadene [Pfizer Laboratories Div Pfizer Inc]

SILVADENE CREAM 1%(silver sulfadiazine)

Cortisporin [Pfizer Laboratories Div Pfizer Inc]

CORTISPORIN Ointment(neomycin and polymyxin B sulfates, bacitracin zinc, and hydrocortisone ointment, USP)

Romidepsin [Pfizer Laboratories Div Pfizer Inc]

These highlights do not include all the information needed to use ROMIDEPSIN safely and effectively.  See full prescribing information for ROMIDEPSIN. ROMIDEPSIN for injection, for intravenous use Initial U.S. Approval:  2009

Bacitracin [Pharmacia and Upjohn Company LLC]

Bacitracin for Injection, USP

Bacitracin [Pharmacia and Upjohn Company LLC]

Bacitracin for Injection, USP

Bosulif [Pfizer Laboratories Div Pfizer Inc]

These highlights do not include all the information needed to use BOSULIF safely and effectively. See full prescribing information for BOSULIF. BOSULIF(bosutinib) tablets, for oral use Initial U.S. Approval: 2012

Cardioxane [Clinigen Healthcare Ltd]

Cardioxane 500 mg Powder for Solution for Infusion

Exondys 51 [Sarepta Therapeutics, Inc.]

These highlights do not include all the information needed to use EXONDYS 51® safely and effectively. See full prescribing information for EXONDYS 51.EXONDYS 51 (eteplirsen) injection, for intravenous useInitial U.S. Approval: 2016

Tigan [Pfizer Laboratories Div Pfizer Inc]

These highlights do not include all the information needed to use TIGANsafely and effectively. See full prescribing information for TIGAN. TIGAN(trimethobenzamide hydrochloride) capsule, for oral use Initial U.S. Approval: 1974

Tapazole [Pfizer Laboratories Div Pfizer Inc]

Tapazole Methimazole Tablets, USP

Cyklokapron [Pharmacia and Upjohn Company LLC]

CYKLOKAPRON tranexamic acid injection

Bacitracin [Pharmacia and Upjohn Company LLC]

Bacitracin for Injection, USP

Bosulif [U.S. Pharmaceuticals]

These highlights do not include all the information needed to use BOSULIF safely and effectively. See full prescribing information for BOSULIF. BOSULIF (bosutinib) tablets, for oral use Initial U.S. Approval: 2012



Advertisement
Quick Search
Advertisement
Advertisement